Bioventix (BVXP)

Sector:

Pharma and Biotech

Index:

FTSE AIM 100

4,160.00p
   
  • Change Today:
      10.00p
  • 52 Week High: 4,500.00
  • 52 Week Low: 2,635.00
  • Currency: UK Pounds
  • Shares Issued: 5.21m
  • Volume: 1,347
  • Market Cap: £216.65m

Growth Ratings

EPS Growth shows the relative growth of a company's earnings over the last year.

The rise in total monies receivable for goods / services sold before expenses.

1yr EPS Growth
0.1% below the market average0.1% below the market average0.1% below the market average0.1% below the market average0.1% below the market average
9.09% below the sector average9.09% below the sector average9.09% below the sector average9.09% below the sector average9.09% below the sector average
1yr Revenue Growth
44.53% above the market average44.53% above the market average44.53% above the market average44.53% above the market average44.53% above the market average
29.41% above the sector average29.41% above the sector average29.41% above the sector average29.41% above the sector average29.41% above the sector average

Income Ratings

The percentage of the share price that a company pays out as dividends over a year.

The percentage change from the previous year in the dividend paid on each share.

Dividend Yield
44.61% below the market average44.61% below the market average44.61% below the market average44.61% below the market average44.61% below the market average
20.00% above the sector average20.00% above the sector average20.00% above the sector average20.00% above the sector average20.00% above the sector average
1yr DPS Growth
73.39% above the market average73.39% above the market average73.39% above the market average73.39% above the market average73.39% above the market average
50.00% above the sector average50.00% above the sector average50.00% above the sector average50.00% above the sector average50.00% above the sector average

Valuation Ratings

The share price as a ratio of revenue per share.

The share price as a ratio of net asset value.

Price Sales Ratio
60.85% above the market average60.85% above the market average60.85% above the market average60.85% above the market average60.85% above the market average
27.27% above the sector average27.27% above the sector average27.27% above the sector average27.27% above the sector average27.27% above the sector average
Price Book Ratio
96.44% below the market average96.44% below the market average96.44% below the market average96.44% below the market average96.44% below the market average
80.77% below the sector average80.77% below the sector average80.77% below the sector average80.77% below the sector average80.77% below the sector average

Performance Ratings

In percentage total change in share price over 30 days.

In percentage total change in share price over 3 months.

Price Chg 30d
11.32% below the market average11.32% below the market average11.32% below the market average11.32% below the market average11.32% below the market average
1.75% below the sector average1.75% below the sector average1.75% below the sector average1.75% below the sector average1.75% below the sector average
Price Chg 3m
10.69% above the market average10.69% above the market average10.69% above the market average10.69% above the market average10.69% above the market average
1.75% below the sector average1.75% below the sector average1.75% below the sector average1.75% below the sector average1.75% below the sector average

Technical Ratings

The Relative Strength Index measures a share price relative to itself and its recent history.

Momentum is an oscillator that measures the rate of price change.

RSI
14.72% below the market average14.72% below the market average14.72% below the market average14.72% below the market average14.72% below the market average
28.57% below the sector average28.57% below the sector average28.57% below the sector average28.57% below the sector average28.57% below the sector average
Momentum 20
62.58% above the market average62.58% above the market average62.58% above the market average62.58% above the market average62.58% above the market average
57.14% above the sector average57.14% above the sector average57.14% above the sector average57.14% above the sector average57.14% above the sector average

Management Ratings

Operating Margin is profit as a percentage of sales.

Return on capital employed measures the return from invested and borrowed capital.

Operating Margin
71.24% above the market average71.24% above the market average71.24% above the market average71.24% above the market average71.24% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
ROCE
75.65% above the market average75.65% above the market average75.65% above the market average75.65% above the market average75.65% above the market average
20.00% above the sector average20.00% above the sector average20.00% above the sector average20.00% above the sector average20.00% above the sector average

Profitability Ratings

Earnings per share, the company's profitability expressed on a per share basis.

Analysts' estimates of future EPS for the next 2 years.

EPS
89.70% above the market average89.70% above the market average89.70% above the market average89.70% above the market average89.70% above the market average
89.29% above the sector average89.29% above the sector average89.29% above the sector average89.29% above the sector average89.29% above the sector average
Forecast EPS
85.62% above the market average85.62% above the market average85.62% above the market average85.62% above the market average85.62% above the market average
69.23% above the sector average69.23% above the sector average69.23% above the sector average69.23% above the sector average69.23% above the sector average

Profit/Loss Ratings

Monies produced from sales of goods and services after trade discounts, VAT, etc.

Operating Profit is the profit after deducting operating costs from gross profits.

Turnover
36.61% below the market average36.61% below the market average36.61% below the market average36.61% below the market average36.61% below the market average
Sector averageSector averageSector averageSector averageSector average
Operating Profit Loss
18.72% above the market average18.72% above the market average18.72% above the market average18.72% above the market average18.72% above the market average
67.86% above the sector average67.86% above the sector average67.86% above the sector average67.86% above the sector average67.86% above the sector average

Balance Sheet Ratings

The difference between current assets and current liabilities.

A current asset representing the company's financial liquidity.

Assets
29.35% below the market average29.35% below the market average29.35% below the market average29.35% below the market average29.35% below the market average
3.7% below the sector average3.7% below the sector average3.7% below the sector average3.7% below the sector average3.7% below the sector average
Cash
11.37% below the market average11.37% below the market average11.37% below the market average11.37% below the market average11.37% below the market average
9.43% below the sector average9.43% below the sector average9.43% below the sector average9.43% below the sector average9.43% below the sector average

Director Deal Ratings

The cumulative amount of stocks sold by company directors over 1 year

The cumulative amount of stocks bought by company directors over 1 year

Sells 1y
33.78% above the market average33.78% above the market average33.78% above the market average33.78% above the market average33.78% above the market average
37.50% above the sector average37.50% above the sector average37.50% above the sector average37.50% above the sector average37.50% above the sector average
Buys 1y
56.76% above the market average56.76% above the market average56.76% above the market average56.76% above the market average56.76% above the market average
64.10% above the sector average64.10% above the sector average64.10% above the sector average64.10% above the sector average64.10% above the sector average

Broker Ratings

The percentage of stockbrokers that rate the company as a Buy

The percentage of stockbrokers that rate the company as a Hold

Brokers Percent Buy Not Available
Brokers Percent Neutral Not Available

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Bioventix Market Data

Currency UK Pounds
Share Price 4,160.00p
Change Today 10.00p
% Change 0.24 %
52 Week High 4,500.00
52 Week Low 2,635.00
Volume 1,347
Shares Issued 5.21m
Market Cap £216.65m

Bioventix Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
98.25% below the market average98.25% below the market average98.25% below the market average98.25% below the market average98.25% below the market average
89.09% below the sector average89.09% below the sector average89.09% below the sector average89.09% below the sector average89.09% below the sector average
Price Trend
82.13% above the market average82.13% above the market average82.13% above the market average82.13% above the market average82.13% above the market average
54.39% above the sector average54.39% above the sector average54.39% above the sector average54.39% above the sector average54.39% above the sector average
Income
76.09% below the market average76.09% below the market average76.09% below the market average76.09% below the market average76.09% below the market average
20% below the sector average20% below the sector average20% below the sector average20% below the sector average20% below the sector average
Growth
34.93% above the market average34.93% above the market average34.93% above the market average34.93% above the market average34.93% above the market average
8.57% above the sector average8.57% above the sector average8.57% above the sector average8.57% above the sector average8.57% above the sector average

Bioventix Dividends

  Latest Previous
  Interim Final
Ex-Div 09-Apr-20 31-Oct-19
Paid 28-Apr-20 15-Nov-19
Amount 36.00p 43.00p

Trades for 10-Jul-2020

Time Volume / Share Price
17:12 237 @ 4,108.97p
16:01 100 @ 4,130.00p
15:50 237 @ 4,125.00p
15:47 60 @ 4,130.00p
15:42 1 @ 4,100.00p

Bioventix Key Personnel

CEO Peter John Harrison
Chair Ian James Nicholson
Finance Director Treena Joan Turner
CFO Bruce Hiscock

Top of Page